Each Serrapeptase Rx VCaps contains 30mg of enteric coated serratia peptidase enzyme preparation (PEPTIZYME) providing 60,000/90,000I.U. of activity, which digests non-living tissue, blood clots, cysts, arterial plaque and inflammation in all forms. The late German physician, Dr. Hans Nieper, used Serrapeptase to treat arterial blockage in his coronary patients. Serrapeptase protects against stroke and is reportedly more effective and quicker than EDTA chelation treatments in removing arterial plaque. He also reports that serrapeptase dissolves blood clots and causes varicose veins to shrink or diminish.
Treatment of Inflammation/Pain:
1 capsule twice per day on an empty stomach or as directed by a health professional.
Treatment for arterial blockage:
1 capsule twice per day on an empty stomach. Up to 6 capsules per day in divided dosages in acute need. Take the highest dose for 7 days until the symptoms decrease substantially and then reduce to 1 per day.
Serrapeptase: A Natural Anti-Inflammatory
Serrapeptase, also known as Serratia Peptidase, is a proteolytic enzyme isolated from the non-pathogenic enterobacteria Serratia E15. When consumed in unprotected tablets or capsules, the enzyme is destroyed by acid in the stomach. However, our special enteric-coated preparation enables the enzyme to pass through the stomach unchanged, and be absorbed in the intestine. Serrapeptase is found in negligible amounts in the urine, suggesting that it is transported directly from the intestine into the bloodstream.
Clinical studies show that serrapeptase induces fibrinolytic, anti-inflammatory and anti-edemic (prevents swelling and fluid retention) activity in a number of tissues, and that its anti-inflammatory effects are superior to other proteolytic enzymes.
Besides reducing inflammation, one of serrapeptase’s most profound benefits is reduction of pain, due to its ability to block the release of pain-inducing amines from inflamed tissues. Physicians throughout Asia and Europe have recognized the anti-inflammatory and pain-blocking benefits of this naturally occurring substance and are using it in treatment as an alternative to salicylates, ibuprofen and other NSAIDs.
In Germany and other European countries, serrapeptase is a common treatment for inflammatory and traumatic swellings, and much of the research that exists on this substance is of European origin. One double-blind study was conducted by German researchers to determine the effect of serrapeptase on post-operative swelling and pain. This study involved sixty-six patients who were treated surgically for fresh rupture of the lateral collateral ligament of the knee. On the third post-operative day, the group receiving serrapeptase exhibited a 50 percent reduction of swelling, compared to the controls. The patients receiving serrapeptase also became more rapidly pain-free than the controls, and by the tenth day, the pain had disappeared completely.
Serrapeptase is thought to work in three ways:
It may reduce inflammation by thinning the fluids formed from injury, and facilitating the fluid’s drainage. This in turn, also speeds tissue repair.
It may help alleviate pain by inhibiting the release of pain-inducing amines called bradykinin.
It may enhance cardiovascular health by breaking down the protein by-products of blood coagulation called fibrin. Conveniently, Serrapeptase is able to dissolve the fibrin and other dead or damaged tissue without harming living tissue. This could enable the dissolution of atherosclerotic plaques without causing any harm to the inside of the arteries.
PEPTIZYME SP?EN, is being used as a highly effective alternative to anti-biotics in many countries. It treats inflammatory disorders by not only fighting inflammation, but also by relieving pain and swelling, improving recovery time and stimulating the immune system. PEPTIZYME SP?has a “scavenging?effect. It helps chelate the heavy metals through which the body releases toxins and hence modulates the immune system, addresses hormonal imbalances and speeds wound and tissue repair time.
PEPTIZYME SP EN is enteric coated-coated granules of Peptizyme SP?derived from a controlled fermentation of the bacterial strain Serratia sp. T-1 secretes this enzyme in medium. Successive purification steps, for example micro-filtration, ammonium sulphate, fractionation, DEAE-Cellulase column chromatography, gel filtration followed by repeat aseptic filtration and freeze drying yields this product in a highly purified form, enabling it to be used for medicinal purpose. The enteric-coated PEPTIZYME SP?EN granules protect the enzyme from inactivation in the acidic medium of the stomach. PEPTIZYME is a stronger caseinolytic (fibrinolytic) agent than any other known alkaline or neutral protease such as bromelain or pronase.
Regardless of whether serrapeptase is used for inflammatory diseases or to prevent plaque build up on the arteries, it is well-tolerated. Due to its lack of side effects and anti-inflammatory capabilities, serrapeptase is a logical choice to replace harmful NSAIDs. Thanks to the tiny larvae of the silk moth, researchers have taken a large step toward finding relief for inflammatory disease sufferers.
For a more complete description including references visit
Serrapeptase: Insect-Derived Enzyme Fights Inflammation.
Packaging: Packed in recyclable amber PETE containers to provide the best protection for the product against oxidation.
Guaranteed Pure: This product contains no added binders, fillers, extenders or other additives.
Capsule Shell: microcrystalline vegetable cellulose and water
PEPTIZYME SP?EN is a registered trade mark of Specialty Enzymes and Biochemicals Co.
VCaps is a trademark of Capsugel.